Use of therapeutic human albumin for treatment of alzheimer'S disease
US7851446B2 · kind B2 · utility
9Cited by
3References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 24, 2008 |
| Grant date | Dec 14, 2010 |
| Priority date | — |
| Expiry date | Oct 24, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of therapeutic human albumin for the preparation of a drug for the treatment of patients suffering from cognitive disorders. In particular, the invention relates to methods of treating patients suffering from cognitive disorders, in which the mode of administration of the drug comprises the administration to the patient for a minimum of three successive times of a therapeutically effective amount of human therapeutic albumin by plasma exchange and/or intravenous perfusion, independently of the content of Aβ in the patient's blood.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.